The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy
Peripartum cardiomyopathy is an uncommon, pregnancy-related form of dilated cardiomyopathy that is associated with development of new-onset left ventricular dysfunction. Its etiology is presently unknown, but current standard of care involves the use of typical drug therapy for the treatment of hear...
Saved in:
Main Authors: | Vamsi C. Gaddipati, Aarti A. Patel, Adam J. Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2017/9561405 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy
by: Martin Lindgren, et al.
Published: (2020-06-01) -
Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
by: Yifei Xu, et al.
Published: (2013-01-01) -
An Incidentally Detected Right Ventricular Pseudoaneurysm
by: Vamsi C. Gaddipati, et al.
Published: (2017-01-01) -
Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
by: Andraz Cerar, et al.
Published: (2020-06-01) -
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
by: Brian P. Halliday, et al.
Published: (2022-06-01)